CVRdatabase
Menu

Pharma-skan ApS

Private limited companyCVR 16275247SkanderborgActive

Pharma-skan ApS is a private limited company, based in Skanderborg, active in manufacture of pharmaceutical preparations, founded in 1992. Net profit fell 30% from 2024 to 2025, ending at DKK 7.9m. Equity fell to DKK 8.5m in 2025. 6 people are registered in the company's management and ownership.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 12.3m−19.2% vs. 2024
Net profitDKK 7.9m−30.2% vs. 2024
EquityDKK 8.5m−55.4% vs. 2024
Employees20latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 19% (2024 → 2025), to DKK 12.3m.
  • Net profit fell 30% (2024 → 2025), to DKK 7.9m.
  • Equity fell 55% (2024 → 2025), to DKK 8.5m.

Employees

  • 3 more employees than a year earlier: 20 (08/2026) against 17 (08/2025).

Management and owners, last 24 months

  • New in management: Ib Gunnar Christensen (director, 31/03/2025), Jan Dam (chair of the board, 31/03/2025) and Kent Ernst Hansen (board member, 31/03/2025) (+3).
  • Stepped down: Ib Gunnar Christensen (director, 30/03/2025) and Susanne Rasmussen (director, 31/03/2025).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12mDKK 14mDKK 16mDKK 18mDKK 20m202020212022202320242025
EquityNet profit
Financial figures for Pharma-skan ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit12,58512,42014,80015,30815,27212,340−19.2%
Operating profit (EBIT)11,95211,72313,96414,56514,20110,142−28.6%
Profit before tax11,85911,62713,94514,74214,47410,096−30.2%
Net profit9,2509,06910,87711,49811,2887,875−30.2%
Total assets23,59221,11223,50123,56123,31016,759−28.1%
Equity17,93517,00418,88119,88019,1688,543−55.4%
Liabilities5,5313,9254,4803,5073,8997,944+103.8%
Cash and cash equivalents16,54711,35415,07812,2527,1341,828−74.4%
Average number of employees141313141315+15.4%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12mDKK 14mDKK 16m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Equity fell sharply

    Equity fell 55% from 2024 to 2025 (DKK 19.2m to DKK 8.5m).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Pharma-skan ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202523/02/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202424/02/2025The companyPDFXBRL
202301/01/2023 – 31/12/202311/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202226/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202109/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202002/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 12.3mNo. 21 of 57
Better than 64% of the companies in the industry
EquityDKK 8.5mNo. 28 of 59
Better than 53% of the companies in the industry
Number of employees20No. 25 of 59
Better than 59% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bnHere
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 4,995of 9,892
Better than 50%
No. 3,432of 9,922
Better than 65%
Companies that are at least 30 years old10,276 companies in the comparison
No. 3,755of 10,152
Better than 63%
No. 5,081of 10,275
Better than 51%
All companies of type ApS66,508 companies in the comparison
No. 4,675of 66,379
Better than 93%
No. 7,681of 66,505
Better than 88%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Pharma-skan ApSDKK 12.3m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Pharma-skan ApSDKK 7.9m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Pharma-skan ApSDKK 8.5m
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Pharma-skan ApS20
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Besula ApS100%
Pharma-skan ApS

Management

6 active registrations

Executive management

Executive management at Pharma-skan ApS
NameRoleAppointed
Ib Gunnar ChristensenDirector31/03/2025
Line WulffCEO31/03/2025

Board of directors

Board of directors at Pharma-skan ApS
NameRoleAppointed
Jan DamChair of the board31/03/2025
Kent Ernst HansenBoard member31/03/2025
Line WulffBoard member31/03/2025
Lars Enghave MinorBoard member12/05/2026
Founders
VX 20.181 ApS
Former management (7)
Former management at Pharma-skan ApS
NameRoleAppointedResigned
Aage RasmussenDirector01/07/199201/04/1998
Per Emil Hasselbalch StakemannDirector01/07/199217/03/1993
Judy RasmussenDirector01/07/199228/12/1994
Susanne RasmussenDirector01/07/199230/04/1999
Ib Gunnar ChristensenDirector01/04/199830/03/2025
Berit Pia RasmussenDirector01/05/199929/05/2017
Susanne RasmussenDirector29/05/201731/03/2025

Signing rule: Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse i forening

Address and production units

1 active production units

Adelgade 27
8660 Skanderborg

Skanderborg Municipality · Postcode 8660

Other companies at the address (1)

  • Skan-medic ApSManufacture of perfumes, shampoo, toothpaste and similar
Production units
Production unitAddressEmployeesP number
PHARMA-SKAN ApSAdelgade 27, 8660 Skanderborg201001070480

Purpose

Selskabets formål er at drive egen samt kontraktproduktion, handel og distribution af lægemidler, medicinske produkter samt andre beslægtede produkter. Selskabet udfører desuden udviklingsrelaterede ydelser for tredjepart samt anden hermed forbundet virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

33 registered events
20262 changesmanagement 1 · accounts 1
  • Lars Enghave Minor appointed board member
  • Annual report for 2025 published
20258 changesmanagement 7 · accounts 1
  • Ib Gunnar Christensen appointed director
  • Line Wulff appointed board member
  • Line Wulff appointed ceo
  • Kent Ernst Hansen appointed board member
  • Jan Dam appointed chair of the board
  • Susanne Rasmussen stepped down as director
  • Ib Gunnar Christensen stepped down as director
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20211 changeaccounts 1
  • Annual report for 2020 published
20201 changeindustry 1
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20172 changesmanagement 2
  • Susanne Rasmussen appointed director
  • Berit Pia Rasmussen stepped down as director
20072 changesaddress 1 · industry 1
  • Moved to Adelgade 27, 8660 Skanderborg
  • Industry changed to Engroshandel med medicinalvarer og sygeplejeartikler (514610)
20061 changeownership 1
  • BESULA ApS registered as owner (100%)
20001 changeaddress 1
  • Moved to Adelgade 27, 8660 Skanderborg
19992 changesmanagement 2
  • Berit Pia Rasmussen appointed director
  • Susanne Rasmussen stepped down as director
19982 changesmanagement 2
  • Ib Gunnar Christensen appointed director
  • Aage Rasmussen stepped down as director
19941 changemanagement 1
  • Judy Rasmussen stepped down as director
19932 changesname 1 · management 1
  • Name changed from ApS KBUS 38 NR. 2587 to PHARMA-SKAN ApS
  • Per Emil Hasselbalch Stakemann stepped down as director
19925 changesfounded 1 · management 4
  • Registered as ApS KBUS 38 NR. 2587
  • Aage Rasmussen appointed director
  • Susanne Rasmussen appointed director
  • Judy Rasmussen appointed director
  • Per Emil Hasselbalch Stakemann appointed director

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction